This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seifer, M.
Right arrow Articles by Standring, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seifer, M.
Right arrow Articles by Standring, D. N.

 Previous Article  |  Next Article 

J Virol, April 1998, p. 2765-2776, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Generation of Replication-Competent Hepatitis B Virus Nucleocapsids in Insect Cells

Maria Seifer, Robert Hamatake, Marc Bifano, and David N. Standring*

Pharmaceutical Research Institute, Bristol-Myers Squibb, Wallingford, Connecticut 06492

Received 15 September 1997/Accepted 6 January 1998

The double-stranded DNA genome of human hepatitis B virus (HBV) and related hepadnaviruses is reverse transcribed from a pregenomic RNA by a viral polymerase (Pol) harboring both priming and RNA- and DNA-dependent elongation activities. Although hepadnavirus replication occurs inside viral nucleocapsids, or cores, biochemical systems for analyzing this reaction are currently limited to unencapsidated Pols expressed in heterologous systems. Here, we describe cis and trans classes of replicative HBV cores, produced in the recombinant baculovirus system via coexpression of HBV core and Pol proteins from either a single RNA (i.e., in cis) or two distinct RNAs (in trans). Upon isolation from insect cells, cis and trans cores contained Pol-linked HBV minus-strand DNA with 5' ends mapping to the authentic elongation origin DR1 and also plus-strand DNA species. Only trans cores, however, were highly active for the de novo priming and reverse transcription of authentic HBV minus strands in in vitro endogenous polymerase assays. This reaction strictly required HBV Pol but not the varepsilon  stem-loop element, although the presence of one varepsilon , or better, two varepsilon s, enhanced minus-strand synthesis up to 10-fold. Compared to unencapsidated Pol enzymes, encapsidated Pol appeared to be (i) highly processive, able to extend minus-strand DNAs of 400 nucleotides from DR1 in vitro, and (ii) more active for HBV plus-strand synthesis. These observations suggest possible contributions to the replication process from the HBV core protein. These novel core reagents should facilitate the analysis of HBV replication in its natural environment, the interior of the capsid, and also fuel the development of new anti-HBV drug screens.


* Corresponding author. Mailing address: Pharmaceutical Research Institute, Bristol-Myers Squibb, 5 Research Parkway, Wallingford, CT 06492. Phone: (203) 284-7573. Fax: (203) 284-6088. E-mail: David_N._Standring{at}ccmail.BMS.com.




This article has been cited by other articles:

  • Jacquard, A.-C., Brunelle, M.-N., Pichoud, C., Durantel, D., Carrouee-Durantel, S., Trepo, C., Zoulim, F. (2006). In Vitro Characterization of the Anti-Hepatitis B Virus Activity and Cross-Resistance Profile of 2',3'-Dideoxy-3'-Fluoroguanosine. Antimicrob. Agents Chemother. 50: 955-961 [Abstract] [Full Text]  
  • Tenney, D. J., Levine, S. M., Rose, R. E., Walsh, A. W., Weinheimer, S. P., Discotto, L., Plym, M., Pokornowski, K., Yu, C. F., Angus, P., Ayres, A., Bartholomeusz, A., Sievert, W., Thompson, G., Warner, N., Locarnini, S., Colonno, R. J. (2004). Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine. Antimicrob. Agents Chemother. 48: 3498-3507 [Abstract] [Full Text]  
  • Lam, W., Li, Y., Liou, J.-Y., Dutschman, G. E., Cheng, Y.-c. (2004). Reverse Transcriptase Activity of Hepatitis B Virus (HBV) DNA Polymerase within Core Capsid: Interaction with Deoxynucleoside Triphosphates and Anti-HBV L-Deoxynucleoside Analog Triphosphates. Mol. Pharmacol. 65: 400-406 [Abstract] [Full Text]  
  • Levine, S., Hernandez, D., Yamanaka, G., Zhang, S., Rose, R., Weinheimer, S., Colonno, R. J. (2002). Efficacies of Entecavir against Lamivudine-Resistant Hepatitis B Virus Replication and Recombinant Polymerases In Vitro. Antimicrob. Agents Chemother. 46: 2525-2532 [Abstract] [Full Text]  
  • Chin, R., Shaw, T., Torresi, J., Sozzi, V., Trautwein, C., Bock, T., Manns, M., Isom, H., Furman, P., Locarnini, S. (2001). In Vitro Susceptibilities of Wild-Type or Drug-Resistant Hepatitis B Virus to ({-})-{beta}-D-2,6-Diaminopurine Dioxolane and 2'-Fluoro-5-Methyl-{beta}-L-Arabinofuranosyluracil. Antimicrob. Agents Chemother. 45: 2495-2501 [Abstract] [Full Text]  
  • Park, S. G., Jung, G. (2001). Human Hepatitis B Virus Polymerase Interacts with the Molecular Chaperonin Hsp60. J. Virol. 75: 6962-6968 [Abstract] [Full Text]  
  • Urban, S., Urban, S., Fischer, K. P., Tyrrell, D. L. (2001). Efficient pyrophosphorolysis by a hepatitis B virus polymerase may be a primer-unblocking mechanism. Proc. Natl. Acad. Sci. USA 98: 4984-4989 [Abstract] [Full Text]  
  • Lanford, R. E., Kim, Y.-H., Lee, H., Notvall, L., Beames, B. (1999). Mapping of the Hepatitis B Virus Reverse Transcriptase TP and RT Domains by Transcomplementation for Nucleotide Priming and by Protein-Protein Interaction. J. Virol. 73: 1885-1893 [Abstract] [Full Text]  
  • Seifer, M., Hamatake, R. K., Colonno, R. J., Standring, D. N. (1998). In Vitro Inhibition of Hepadnavirus Polymerases by the Triphosphates of BMS-200475 and Lobucavir. Antimicrob. Agents Chemother. 42: 3200-3208 [Abstract] [Full Text]